massively parallel sequencing (mps) (Illumina Inc)
Illumina Inc is a verified supplier 
90
Structured Review
Illumina Inc
massively parallel sequencing (mps)
Massively Parallel Sequencing (Mps), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parallel+sequencing+mps/massively+parallel+sequencing/pm40446366-84-10-13
Average 90 stars, based on 1 article reviews
Massively Parallel Sequencing (Mps), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parallel+sequencing+mps/massively+parallel+sequencing/pm40446366-84-10-13
Average 90 stars, based on 1 article reviews
massively parallel sequencing (mps) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Sequencing:Article Title: Hybrid glycophorins: Silent genetic variants complicate genetic testing Article Snippet: .. Analysis of all variants in 33/36 blood group systems for 29 samples with known extended genotypes was performed by massively Article Title: BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study. Article Snippet: Objective.. The aim of this study was to assess the correlation between BRCA mutation status and disease presentation, treatment strategy, and survival in a multicenter series of recurrent high-grade serous ovarian cancer (HGSOC) women.. Methods. Article Title: Evaluation of snp microarray based chromosome testing for detection of prognostically relevant genomic abnormalities in chronic lymphocytic leukaemia Article Snippet: S S97 diagnosis of genetically heterogeneous disorders such as the hereditary ataxias.. IN PRAISE OF ANELOVIRUSES, SAVIOURS OF THE NUCLEOTIDE ECONOMY: A CASE BASED ON EVIDENCE FROM SYNTHETIC BIOLOGY AND GENETICS Tim Shaw, Andrew Peel 1Victorian Infectious Diseases Reference Laboratory, The Doherty Institute, and 2Department of Computing and Information Systems, The University of Melbourne, Melbourne, Mutagenesis:Article Title: BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study. Article Snippet: Objective.. The aim of this study was to assess the correlation between BRCA mutation status and disease presentation, treatment strategy, and survival in a multicenter series of recurrent high-grade serous ovarian cancer (HGSOC) women.. Methods. |